A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
Seattle Children's Hospital
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Beth Israel Deaconess Medical Center
M.D. Anderson Cancer Center
University of Pennsylvania
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Centre Antoine Lacassagne
Georgetown University
Seattle Children's Hospital
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
Children's Hospital of Philadelphia
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Massachusetts General Hospital
University College, London
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
Dana-Farber Cancer Institute
Seattle Children's Hospital
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
University of Pennsylvania
Seattle Children's Hospital
Seattle Children's Hospital
Montreal Heart Institute
Rigshospitalet, Denmark
City of Hope Medical Center
City of Hope Medical Center
Peking University First Hospital
Memorial Sloan Kettering Cancer Center
University of Virginia
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Tampere University Hospital